Search research articles
Contact Us
Filters
Showing results (321-330 of 392) with videos related to
Page
of 40
Sort By:
Annals of Neurology
|
September 8, 2015
Validating novel tau positron emission tomography tracer [F-18]-AV-1451 (T807) on postmortem brain tissue
Marta Marquié, Marc D Normandin, Charles R Vanderburg, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
January 8, 2026
Identifying early changes in imaging, plasma, and digital cognitive biomarkers that correspond to Alzheimer's disease pathology in the presence of autopsy-confirmed co-pathologies
Charles D Chen, Cinthya Aguero, Alexandra Melloni, et al.
Neurobiology of Aging
|
May 29, 2012
Apolipoprotein E ε4 and age effects on florbetapir positron emission tomography in healthy aging and Alzheimer disease
Adam S Fleisher, Kewei Chen, Xiaofen Liu, et al.
JAMA Neurology
|
July 18, 2019
Associations of Physical Activity and β-Amyloid With Longitudinal Cognition and Neurodegeneration in Clinically Normal Older Adults
Jennifer S Rabin, Hannah Klein, Dylan R Kirn, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
November 7, 2023
Plasma Aβ42/Aβ40 and phospho-tau217 concentration ratios increase the accuracy of amyloid PET classification in preclinical Alzheimer's disease
Robert A Rissman, Oliver Langford, Rema Raman, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
February 5, 2013
Florbetapir (F18-AV-45) PET to assess amyloid burden in Alzheimer's disease dementia, mild cognitive impairment, and normal aging
Keith A Johnson, Reisa A Sperling, Christopher M Gidicsin, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
April 24, 2025
Elevated serum cortisol associated with early-detected increase of brain amyloid deposition in Alzheimer's disease imaging biomarkers among menopausal women: The Framingham Heart Study
Arash Salardini, Jayandra J Himali, Muhammad S Abdullah, et al.
Medrxiv : the Preprint Server for Health Sciences
|
July 17, 2025
BrainAge moderates associations between Alzheimer's disease biomarkers and cognitive decline: a meta-analysis across A4/LEARN, HABS and ADNI cohorts
Jorge Garcia Condado, Hannah M Klinger, Colin Birkenbihl, et al.
Biorxiv : the Preprint Server for Biology
|
December 15, 2025
Blood-based Transcriptomics Reveal Sex- and Amyloid-Modulated Biology of Plasma pTau217 in Preclinical Alzheimer's Disease
Mabel Seto, Hannah M Klinger, Michelle Clifton, et al.
The Lancet. Neurology
|
May 16, 2016
Cortical atrophy in patients with cerebral amyloid angiopathy: a case-control study
Panagiotis Fotiadis, Sanneke van Rooden, Jeroen van der Grond, et al.
Page
of 40
Search research articles
Search
Showing results (321-330 of 392) with videos related to
Sort By:
Page
of 40
Annals of Neurology
|
September 8, 2015
Validating novel tau positron emission tomography tracer [F-18]-AV-1451 (T807) on postmortem brain tissue
Marta Marquié, Marc D Normandin, Charles R Vanderburg, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
January 8, 2026
Identifying early changes in imaging, plasma, and digital cognitive biomarkers that correspond to Alzheimer's disease pathology in the presence of autopsy-confirmed co-pathologies
Charles D Chen, Cinthya Aguero, Alexandra Melloni, et al.
Neurobiology of Aging
|
May 29, 2012
Apolipoprotein E ε4 and age effects on florbetapir positron emission tomography in healthy aging and Alzheimer disease
Adam S Fleisher, Kewei Chen, Xiaofen Liu, et al.
JAMA Neurology
|
July 18, 2019
Associations of Physical Activity and β-Amyloid With Longitudinal Cognition and Neurodegeneration in Clinically Normal Older Adults
Jennifer S Rabin, Hannah Klein, Dylan R Kirn, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
November 7, 2023
Plasma Aβ42/Aβ40 and phospho-tau217 concentration ratios increase the accuracy of amyloid PET classification in preclinical Alzheimer's disease
Robert A Rissman, Oliver Langford, Rema Raman, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
February 5, 2013
Florbetapir (F18-AV-45) PET to assess amyloid burden in Alzheimer's disease dementia, mild cognitive impairment, and normal aging
Keith A Johnson, Reisa A Sperling, Christopher M Gidicsin, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
April 24, 2025
Elevated serum cortisol associated with early-detected increase of brain amyloid deposition in Alzheimer's disease imaging biomarkers among menopausal women: The Framingham Heart Study
Arash Salardini, Jayandra J Himali, Muhammad S Abdullah, et al.
Medrxiv : the Preprint Server for Health Sciences
|
July 17, 2025
BrainAge moderates associations between Alzheimer's disease biomarkers and cognitive decline: a meta-analysis across A4/LEARN, HABS and ADNI cohorts
Jorge Garcia Condado, Hannah M Klinger, Colin Birkenbihl, et al.
Biorxiv : the Preprint Server for Biology
|
December 15, 2025
Blood-based Transcriptomics Reveal Sex- and Amyloid-Modulated Biology of Plasma pTau217 in Preclinical Alzheimer's Disease
Mabel Seto, Hannah M Klinger, Michelle Clifton, et al.
The Lancet. Neurology
|
May 16, 2016
Cortical atrophy in patients with cerebral amyloid angiopathy: a case-control study
Panagiotis Fotiadis, Sanneke van Rooden, Jeroen van der Grond, et al.
Page
of 40